Leeds Assessment of Neuropathic Symptoms and Signs (LANSS): Difference between revisions
No edit summary |
(Created initial content) |
||
| Line 6: | Line 6: | ||
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} | '''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} | ||
</div> | </div> | ||
== Objective< | == Objective == | ||
The LANSS was developed to provide a simple clinical tool that can be used to distinguish between neuropathic pain and nociceptive pain - it is used to determine whether neuropathic mechanisms dominate a patient's pain experience<ref>Bennett M. [https://www.researchgate.net/publication/12013304_The_LANSS_pain_scale_The_Leeds_Assessment_of_Neuropathic_Symptoms_and_Signs The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.] Pain. 2001 May 1;92(1-2):147-57.</ref>. By identifying neuropathic pain mechanisms, more individualised treatment can follow. It was developed in 2001, and an alternative scale, | |||
== Intended Population | == Intended Population == | ||
== Method of Use == | == Method of Use == | ||
== Reference | == Reference == | ||
== Evidence == | == Evidence == | ||
| Line 22: | Line 23: | ||
=== Responsiveness === | === Responsiveness === | ||
=== Miscellaneous | === Miscellaneous === | ||
== Links == | == Links == | ||
'''[https://bpac.org.nz/BPJ/2016/May/docs/s-lanss.pdf S-LANSS Pain Score]''' | |||
== References == | == References == | ||
<references /> | <references /> | ||
Revision as of 09:29, 26 July 2023
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (26/07/2023)
Original Editor - Melissa Coetsee
Top Contributors - Melissa Coetsee
Objective[edit | edit source]
The LANSS was developed to provide a simple clinical tool that can be used to distinguish between neuropathic pain and nociceptive pain - it is used to determine whether neuropathic mechanisms dominate a patient's pain experience[1]. By identifying neuropathic pain mechanisms, more individualised treatment can follow. It was developed in 2001, and an alternative scale,
Intended Population[edit | edit source]
Method of Use[edit | edit source]
Reference[edit | edit source]
Evidence[edit | edit source]
Reliability[edit | edit source]
Validity[edit | edit source]
Responsiveness[edit | edit source]
Miscellaneous[edit | edit source]
Links[edit | edit source]
References[edit | edit source]
- ↑ Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001 May 1;92(1-2):147-57.
